These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Characteristics of TIMP1, CD63, and β1-Integrin and the Functional Impact of Their Interaction in Cancer. Justo BL; Jasiulionis MG Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502227 [TBL] [Abstract][Full Text] [Related]
11. Establishment of Structure-Function Relationship of Tissue Inhibitor of Metalloproteinase-1 for Its Interaction with CD63: Implication for Cancer Therapy. Warner RB; Najy AJ; Jung YS; Fridman R; Kim S; Kim HC Sci Rep; 2020 Feb; 10(1):2099. PubMed ID: 32034211 [TBL] [Abstract][Full Text] [Related]
12. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury. Yang K; Palm J; König J; Seeland U; Rosenkranz S; Feiden W; Rübe C; Rübe CE Int J Radiat Biol; 2007 Oct; 83(10):665-76. PubMed ID: 17729161 [TBL] [Abstract][Full Text] [Related]
13. Regulation of Tumor Metabolism and Extracellular Acidosis by the TIMP-10-CD63 Axis in Breast Carcinoma. Najy AJ; Jung YS; Kim S; Fridman R; Kim HC Cells; 2021 Oct; 10(10):. PubMed ID: 34685701 [TBL] [Abstract][Full Text] [Related]
14. Tissue Inhibitor of Matrix Metalloproteinase-1 Promotes Myocardial Fibrosis by Mediating CD63-Integrin β1 Interaction. Takawale A; Zhang P; Patel VB; Wang X; Oudit G; Kassiri Z Hypertension; 2017 Jun; 69(6):1092-1103. PubMed ID: 28373589 [TBL] [Abstract][Full Text] [Related]
15. Co-expression of TIMP-1 and its cell surface binding partner CD63 in glioblastomas. Aaberg-Jessen C; Sørensen MD; Matos ALSA; Moreira JM; Brünner N; Knudsen A; Kristensen BW BMC Cancer; 2018 Mar; 18(1):270. PubMed ID: 29523123 [TBL] [Abstract][Full Text] [Related]
16. The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling. Forte D; Salvestrini V; Corradi G; Rossi L; Catani L; Lemoli RM; Cavo M; Curti A Oncotarget; 2017 Jan; 8(2):2261-2274. PubMed ID: 27903985 [TBL] [Abstract][Full Text] [Related]
17. Tissue inhibitor of metalloproteinases-1 induces a pro-tumourigenic increase of miR-210 in lung adenocarcinoma cells and their exosomes. Cui H; Seubert B; Stahl E; Dietz H; Reuning U; Moreno-Leon L; Ilie M; Hofman P; Nagase H; Mari B; Krüger A Oncogene; 2015 Jul; 34(28):3640-50. PubMed ID: 25263437 [TBL] [Abstract][Full Text] [Related]
18. MMP1 drives tumor progression in large cell carcinoma of the lung through fibroblast senescence. Gabasa M; Radisky ES; Ikemori R; Bertolini G; Arshakyan M; Hockla A; Duch P; Rondinone O; Llorente A; Maqueda M; Davalos A; Gavilán E; Perera A; Ramírez J; Gascón P; Reguart N; Roz L; Radisky DC; Alcaraz J Cancer Lett; 2021 Jun; 507():1-12. PubMed ID: 33684534 [TBL] [Abstract][Full Text] [Related]
19. Verapamil inhibited the development of ureteral stricture by blocking CaMK II-mediated STAT3 and Smad3/JunD pathways. Qing Z; Yuan W; Wang J; Song W; Luo J; Wu X; Lu Q; Li Y; Zeng M Int Urol Nephrol; 2022 Nov; 54(11):2855-2866. PubMed ID: 35922702 [TBL] [Abstract][Full Text] [Related]
20. Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylation. Toricelli M; Melo FH; Peres GB; Silva DC; Jasiulionis MG Mol Cancer; 2013 Mar; 12():22. PubMed ID: 23522389 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]